MAQUET Cardiac Assist - MEGA™ 8Fr. 50cc IABP Catheter

By: Datascope  09-12-2011

Overview

It's time for a new frame of reference when selecting the right intra-aortic balloon for counterpulsation therapy. Introducing the MEGA 8Fr. 50cc IAB: the world's first 50cc IAB catheter on a true 8Fr. shaft. An ideal choice for patients 5'4"(162cm) and taller - brought to you by MAQUET, a proven leader in cardiovascular technology.

Improved Performance Compared to 40cc IABs. The MEGA IAB delivers 50cc at a comparable cycle time to 40cc IABs, while offering:

  • 25% more blood volume displacement*
  • Improved unloading and augmentation*

Greater Options: Depending on clinician preference, the MEGA may be inserted sheathless or through an 8Fr. sheath, replaces traditional 50cc IABs, and can also be used for patients that need greater augmentation.

WE WROTE THE BOOK ON IAB CATHETERS
NOW WE'VE REWRITTEN THE CHART

With new height and sizing guidelines for patients 5'4" (162cm) and taller, the benefits of a 50cc IAB are now available for smaller patients.

Smaller is Better: The unique balloon wrap provides a true 8Fr. profile. The catheter cross section area for the MEGA is 24% smaller than a 10.5Fr. IAB – and a smaller catheter size can:

  • Improve distal limb blood flow*
  • Lower ischemia rates*

Premium Durathane Blow-Molded Balloon Membrane. The MEGA balloon membrane consists of a Premium Durathane Blow-Molded Balloon Membrane that offers:

  • Abrasion resistance improved 43%*
  • Improved fatigue resistance*
  • Reduced insertion force*
  • Immediate inflation at start-up*


Contact Datascope

Email - none provided

Print this page

Other products and services from Datascope

09-12-2011

MAQUET Cardiac Assist - SAFEGUARD

The SAFEGUARD Manual Assist Technique clinical trial demonstrates that SAFEGUARD 24cm is safe and effective in reducing active compression time in femoral artery cannulation following diagnostic and interventional procedures. SAFEGUARD provides hands-free adjustable pressure while simplifying pre and post hemostasis management of the access site; providing the dual benefit of a sterile dressing with site visibility.